Edoxaban tosylate monohydrate
mRNA synthesis
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Inhibitor Cocktails
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
作为一种关键的丝氨酸蛋白酶,Xa因子(FXa)是预防及治疗血栓栓塞性疾病的潜在靶酶。Edoxaban tosylate monohydrate是新型的能够直接抑制FXa活性的抗血栓药。
体外实验:Edoxaban tosylate monohydrate (DU-176b)抑制FXa,其对游离FXa和凝血酶原酶的Ki值分别为0.561 nM和2.98 nM,对FXa表现出超过10 000倍的选择性。DU-176b使人血浆中凝血酶原时间加倍,活化部分凝血酶原时间。DU-176b并不影响由ADP、胶原或U46619引起的血小板聚集[1]。
体内试验:DU-176b剂量依赖性抑制大鼠和兔血栓形成模型中的血栓形成,虽然在抗血栓形成的剂量下大鼠的流血时间并没有显著延长[1]。
临床试验:先前的研究证明了人口服[14C] Edoxaban后的物料平衡和药代动力学。物料平衡试验表明不变的Edoxaban是最主要的成分。Edoxaban会通过多种途径排出,但每种途径的排出量仅占总体排出量的一小部分[2].
参考文献:
[1] Furugohri T, Isobe K, Honda Y, Kamisato-Matsumoto C, Sugiyama N, Nagahara T, Morishima Y, Shibano T. DU-176b, a potent and orally active factor Xa inhibitor: in vitro and in vivo pharmacological profiles. J Thromb Haemost. 2008;6(9):1542-9.
[2] Bathala MS, Masumoto H, Oguma T, He L, Lowrie C, Mendell J. Pharmacokinetics, biotransformation, and mass balance of edoxaban, a selective, direct factor Xa inhibitor, in humans. Drug Metab Dispos. 2012;40(12):2250-5.
Physical Appearance | A solid |
Storage | Store at -20°C |
M.Wt | 738.27 |
Cas No. | 1229194-11-9 |
Formula | C31H40ClN7O8S2 |
Solubility | ≥36.91 mg/mL in DMSO; insoluble in H2O; ≥5.78 mg/mL in EtOH with gentle warming and ultrasonic |
Chemical Name | N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide;4-methylbenzenesulfonic acid;hydrate |
SDF | Download SDF |
Canonical SMILES | CC1=CC=C(C=C1)S(=O)(=O)O.CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C.O |
运输条件 | 蓝冰运输或根据您的需求运输。 |
一般建议 | 不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。 |
质量控制和MSDS
- 批次: